glutathione parkinson's disease therapy perlmutter The ongoing pursuit of neuroprotective therapies in Parkinson Research progress on intranasal treatment

The peptide demonstrates remarkable stability in gastric acid, with arginate salt formulations achieving over 90% bioavailability through oral administration

The choice between injections and pills depends on individual needs, including deficiency severity and absorption capacity

This could be because they huffed a lot at the time, or they might have other health conditions (like anemia) or a pre-existing vitamin B12 deficiency

Archived from the original on 13 April 2023

For context, CagriSema's GI rate was compared to its individual components: semaglutide alone and cagrilintide alone both had lower GI event rates than the combination, consistent with additive GI effects

BPC-157 Australia FAQ